MDM2 Inhibition as a New Treatment Approach in AML

被引：0
|
作者：
Konopleva, Marina [1 ,2 ]
机构：
[1] Univ Texas Hlth Sci Ctr Houston, Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
[2] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
来源：
ANNALS OF HEMATOLOGY | 2019年 / 98卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S74 / S75
页数：2
相关论文
共 50 条
  • [1] OPTIMIZING MDM2 INHIBITION FOR THE TREATMENT OF GLIOBLASTOMA
    Rendo, Veronica
    Lee, Eudocia
    Khuu, Nicholas
    Pelton, Kristine
    Lapinskas, Emily
    Wen, Patrick Y.
    Ligon, Keith
    Beroukhim, Rameen
    [J]. NEURO-ONCOLOGY, 2022, 24 : 213 - 213
  • [2] Pharmacological inhibition of WIP1 sensitizes AML cells to MDM2 inhibitors
    Fontana, Maria Chiara
    Nanni, Jacopo
    Simonetti, Giorgia
    di Rora, Andrea Ghelli Luserna
    Padella, Antonella
    Bruno, Samantha
    Papayannidis, Cristina
    Marconi, Giovanni
    Abbenante, Mariachiara
    Cavo, Michele
    Martinelli, Giovanni
    [J]. CANCER RESEARCH, 2018, 78 (13)
  • [3] FLT3 and MDM2 expression are biomarkers for combined MDM2 and MEK inhibition treatment in acute myeloid leukemia
    Seipel, K.
    Marques, M. A.
    Sidler, C.
    Mueller, B. U.
    Pabst, T.
    [J]. SWISS MEDICAL WEEKLY, 2018, 148 : 24S - 24S
  • [4] OPTIMIZING MDM2 INHIBITION FOR THE TREATMENT OF HIGH-GRADE GLIOMA
    Rendo, Veronica
    Lupien, Leslie
    Khuu, Nicholas
    Pelton, Kristine
    Elcavage, Lara
    Lu, Sophie
    Khadka, Prasidda
    Langhnoja, Jaldeep
    Phoenix, Tim
    Ligon, Keith
    Bandopadhayay, Pratiti
    Beroukhim, Rameen
    [J]. NEURO-ONCOLOGY, 2021, 23 : 77 - 77
  • [5] MDM2 Inhibition in the Treatment of Glioblastoma: From Concept to Clinical Investigation
    Ortiz, Karolina Pellot I.
    Rechberger, Julian S.
    Nonnenbroich, Leo F.
    Daniels, David J.
    Sarkaria, Jann N.
    [J]. BIOMEDICINES, 2023, 11 (07)
  • [6] MDM2 inhibition in combination with MEK inhibition in pre-clinical models of lung adenocarcinomas with MDM2 amplification
    Elkrief, Arielle
    Markov, Vladimir
    Quintanal-Villalonga, Alvaro
    Caeser, Rebecca
    Sobczuk, Pawel
    Cheng, Emily
    Drilon, Alexander
    Riely, Gregory J.
    Lockwood, William W.
    de Stanchina, Elisa
    Rudin, Charles M.
    Odintsov, Igor
    Somwar, Romel
    [J]. CANCER RESEARCH, 2023, 83 (07)
  • [7] Identifying the determinants of response to MDM2 inhibition
    Saiki, Anne Y.
    Caenepeel, Sean
    Cosgrove, Elissa
    Su, Cheng
    Boedigheimer, Michael
    Oliner, Jonathan D.
    [J]. ONCOTARGET, 2015, 6 (10) : 7701 - 7712
  • [8] Characterize Biomarkers and Mechanisms of Resistance for MDM2 Inhibitors in AML
    Savoy, Lindsey
    Bottomly, Daniel
    Chen, Reid
    Allen, Basil
    Tyner, Jeffrey W.
    McWeeney, Shannon K.
    Zhang, Haijiao
    [J]. BLOOD, 2022, 140 : 8778 - 8779
  • [9] Inhibition of MDM2 homodimerization by XIAP IRES stabilizes MDM2, influencing cancer cell survival
    Tao Liu
    Hailong Zhang
    Jing Xiong
    Sha Yi
    Lubing Gu
    Muxiang Zhou
    [J]. Molecular Cancer, 14
  • [10] MDM2 inhibition augments GVL effect
    Bleakley, Marie
    Biernacki, Melinda
    [J]. BLOOD, 2022, 140 (10) : 1064 - 1065
12345